Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 8th CNS Drug Delivery Summit.

Pharma Leaders Advancing the Future of CNS Drug Delivery
Biotech Innovators Redefining Brain Access & Therapeutic Delivery
Academicians, Investors & Strategic Architects Shaping the Next Wave of Neuro Innovation
Clinical & Translational Specialists De-Risking Brain Delivery Programs

Pharma Leaders Advancing the Future of CNS Drug Delivery

Didier Lefebvre, Research Fellow, Drug Delivery Sciences at AbbVie speaking at the 8th CNS Drug Delivery Summit

Didier Lefebvre

Research Fellow, Drug Delivery Sciences
Abbvie
Muthiah Manoharan, Senior Vice President Innovation Chemistry at Alnylam Pharmaceuticals at the 8th CNS Drug Delivery Summit

Muthiah Manoharan

Senior Vice President - Innovation Chemistry & Alnylam Distinguished Scientist
Alnylam Pharmaceuticals
Ross Jeggo, Senior Vice President Global Neurology Research at Biogen speaking at the 8th CNS Drug Delivery Summit

Ross Jeggo

Senior Vice President, Global Neurology Research
Biogen
Andrew East, Head of IDU Device Development and Manufacturing at Biogen at the 8th CNS Drug Delivery Summit

Andrew East

Head of IDU Device Development & Manufacturing
Biogen
Janelle Arrambide, Head of Device Clinical at Biogen speaking at the 8th CNS Drug Delivery Summit

Janelle Arrambide

Head of Device Clinical
Biogen
Sonu Kumar, Principal Scientist at Bristol Myers Squibb attending the 8th CNS Drug Delivery Summit

Sonu Kumar

Principal Scientist
Bristol Myers Squibb
Akihiro Furukawa, Global Director Research and Technology Search and Evaluation at Daiichi Sankyo

Akihiro Furukawa

Global Director, Research & Technology Search & Evaluation
Daiichi Sankyo
Christopher Kadamus, Former Executive Director of Engineering DDCS at Eli Lilly at the CNS Drug Delivery Summit

Christopher Kadamus

Former Executive Director of Engineering, DDCS (Delivery, Device, & Connected Solutions)
Eli Lilly
Hugh Nuthall, Executive Director Search and Evaluation Neuroscience at Eli Lilly speaking at the summit

Hugh Nuthall

Executive Director Search and Evaluation Neuroscience
Eli Lilly
Ajit D'Souza, Executive Director Drug Delivery and Devices at Eli Lilly speaking at the CNS event

Ajit D’Souza

Executive Director, Drug Delivery & Devices DDCS
Eli Lilly
Kaitlyn Eddy, Principal Engineer Delivery Device and Connected Solutions at Eli Lilly

Kaitlyn Eddy

Principal Engineer, Delivery, Device, and Connected Solutions (DDCS)
Eli Lilly
Allan Jensen, Vice President Biotherapeutic Discovery at Lundbeck attending the 8th CNS Drug Delivery Summit

Allan Jensen

Vice President, Biotherapeutic Discovery
Lundbeck
Sophie Parmentier-Batteur, Head of Neurodegeneration at Novartis attending the CNS Drug Delivery Summit

Sophie Parmentier-Batteur

Head of Neurodegeneration
Novartis
Lipa Shah, Director Novel Delivery Technologies at Novartis speaking at the 8th CNS Drug Delivery Summit

Lipa Shah

Director, Novel Delivery Technologies
Novartis
Robert Esterberg

Robert Esterberg

Investigator
Novartis
Urs Langen, Lab Head and Research Project Leader at Roche speaking at the 8th CNS Drug Delivery Summit

Urs Langen

Lab Head & Research Project Leader
Roche
Peter Horanyi, Senior Principal Scientist at UCB attending the 8th CNS Drug Delivery Summit

Peter Horanyi

Senior Principal Scientist
UCB

Biotech Innovators Redefining Brain Access & Therapeutic Delivery

Paul Shughrue, Vice President, Program Leader and Head of Research at Acumen speaking at the 8th CNS Drug Delivery Summit

Paul Shughrue

Vice President, Program Leader & Head of Research
Acumen
Christopher Davis

Christopher Davis

Director, Nonclinical & Translational Research
Apertura Gene Therapy
Mathias Schmidt, President and Chief Executive Officer of ArmaGen and JCR Pharmaceuticals at the 8th CNS Drug Delivery Summit

Mathias Schmidt

President & Chief Executive Officer
ArmaGen & JCR Pharmaceuticals
Susana Correia, Director of Neuromuscular Research at Dyne Therapeutics speaking at the 8th CNS Drug Delivery Summit

Susana Correia

Director, Neuromuscular Research
Dyne Therapeutics
Ajay Verma, Founding Scientist at Lotus Neuroscience attending the 8th CNS Drug Delivery Summit

Ajay Verma

Founding Scientist
Lotus Neuroscience
Mathias Schmidt

Matthias Langhorst

Chief Commercial Officer
Noselab
Meena Meena, Senior Vice President of Translational DMPK and Clinical Pharmacology at Stoke Therapeutics

Meena Meena

Senior Vice President, Translational DMPK & Clinical Pharmacology
Stoke Therapeutics
Mathieu Nonnenmacher, Vice President of Gene Therapy at Voyager Therapeutics speaking at the CNS Drug Delivery Summit

Mathieu Nonnenmacher

Vice President, Gene Therapy
Voyager Therapeutics
Sarah Lamore, Senior Director of Toxicology at Wave Life Sciences attending the 8th CNS Drug Delivery Summit

Sarah Lamore

Senior Director, Toxicology
Wave Life Sciences

Academicians, Investors & Strategic Architects Shaping the Next Wave of Neuro Innovation

Andrew Steinsapir, Director and Gene Therapy Program Lead at Deerfield speaking at the 8th CNS Drug Delivery Summit

Andrew Steinsapir

Director - Gene Therapy Program Lead
Deerfield
Sophia Shi, Principal Investigator at the Rowland Institute Harvard University speaking at the 8th CNS Drug Delivery Summit

Sophia Shi

Principal Investigator
Rowland Institute, Harvard University
Miles Gerson, Partner at SV Health Investors attending the 8th CNS Drug Delivery Summit

Miles Gerson

Partner
SV Health Investors
James Gorman, Principal Investigator of the Brain Targeting Program at Wyss Institute Harvard Medical School

James Gorman

Principal Investigator, Brain Targeting Program
WYSS Institute, Harvard Medical School

Clinical & Translational Specialists De-Risking Brain Delivery Programs

Olivier Kitten, Founder and Chief Executive Officer of Affilogic speaking at the 8th CNS Drug Delivery Summit

Olivier Kitten

Founder & Chief Executive Officer
Affilogic
Bill Jackson, Founder and Chief Executive Officer of Base Pair Biotechnologies at the 8th CNS Drug Delivery Summit

Bill Jackson

Founder & Chief Executive Officer
Base Pair Technologies
Conference delegates participating in sessions at the 8th CNS Drug Delivery Summit
Explore the Agenda

Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 25+ expert speakers shaping the future of CNS drug delivery.

View Presentations & Speakers
Sponsor exhibition area at the 8th CNS Drug Delivery Summit
Partner With Us

Showcase your solutions, connect with decision makers, and position your company as the go-to provider to CNS drug developers focused on brain delivery.

Explore Sponsorship Options
Conference delegates participating in sessions at the 8th CNS Drug Delivery Summit
Join Biopharma Experts

Network with pharma, biotech, diagnostics, academia, consortia, and regulatory voices driving real-world adoption.

Register Now